{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:56:54Z","timestamp":1785463014622,"version":"3.56.0"},"reference-count":25,"publisher":"Akademiai Kiado Zrt.","issue":"40","license":[{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2023,10,8]]},"abstract":"<jats:p>A szerzett haemophilia A ritka, de \u00e9letvesz\u00e9lyes v\u00e9rz\u00e9seket okoz\u00f3 k\u00f3rk\u00e9p,\n                    amelynek felismer\u00e9se \u00e9s kezel\u00e9se a perioperat\u00edv id\u0151szakban jelent\u0151s kih\u00edv\u00e1st\n                    jelent az aneszteziol\u00f3gusok sz\u00e1m\u00e1ra. A gyors diagnosztik\u00e1ban lehet seg\u00edts\u00e9g\u00fcnkre\n                    a viszkoelasztometria alkalmaz\u00e1sa, amely alapj\u00e1n, ha felmer\u00fcl a bels\u0151\n                    v\u00e9ralvad\u00e1si \u00fat izol\u00e1lt, s\u00falyos zavara, azonnal hematol\u00f3giai centrummal kell\n                    felvenn\u00fcnk a kapcsolatot. A speci\u00e1lis v\u00e9ralvad\u00e1si laborat\u00f3riumi vizsg\u00e1latok\n                    seg\u00edtenek az \u00e9szlelt alvad\u00e1si zavar differenci\u00e1ldiagnosztik\u00e1j\u00e1ban. A\n                    perioperat\u00edv szakban jelentkez\u0151 v\u00e9rz\u00e9s ell\u00e1t\u00e1s\u00e1ban kiemelt szerep\u00fck van az \u00fan.\n                    \u2019bypassing\u2019 szereknek, melyek megker\u00fclve az autoantitestek \u00e1ltal inaktiv\u00e1lt\n                    VIII-as faktort, beind\u00edtj\u00e1k a v\u00e9ralvad\u00e1st. A kezel\u00e9sben a v\u00e9rz\u00e9s sor\u00e1n\n                    elvesztett alvad\u00e1si faktorok korai, c\u00e9lzott p\u00f3tl\u00e1s\u00e1ra is fokozott figyelmet kell\n                    ford\u00edtanunk. Orv Hetil. 2023; 164(40): 1600\u20131604.<\/jats:p>","DOI":"10.1556\/650.2023.32874","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:13:39Z","timestamp":1697710419000},"page":"1600-1604","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":1,"title":["A szerzett haemophilia A gyors diagnosztik\u00e1ja ClotPro viszkoelasztometri\u00e1s k\u00e9sz\u00fcl\u00e9kkel"],"prefix":"10.1556","volume":"164","author":[{"given":"Gy\u00f6ngyi","family":"T\u00f3th","sequence":"first","affiliation":[{"name":"Budapesti Uzsoki Utcai K\u00f3rh\u00e1z, K\u00f6zponti Aneszteziol\u00f3giai \u00e9s Intenz\u00edv Ter\u00e1pi\u00e1s Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Z\u00e1troch","sequence":"additional","affiliation":[{"name":"Budapesti Uzsoki Utcai K\u00f3rh\u00e1z, K\u00f6zponti Aneszteziol\u00f3giai \u00e9s Intenz\u00edv Ter\u00e1pi\u00e1s Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Kiss","sequence":"additional","affiliation":[{"name":"Budapesti Uzsoki Utcai K\u00f3rh\u00e1z, Ortop\u00e9d-Traumatol\u00f3giai Oszt\u00e1ly Budapest Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Fazakas","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Aneszteziol\u00f3giai \u00e9s Intenz\u00edv Ter\u00e1pi\u00e1s Klinika Budapest, Pf. 2, 1428 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Kov\u00e1cs A, Tajti B, Szoboszlay I, et al. Successful treatment of acquired haemophilia A. [A szerzett haemophilia A sikeres kezel\u00e9se.] Orv Hetil. 2021; 162: 1977-1981. [Hungarian]","DOI":"10.1556\/650.2021.32245"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1538-7836.2007.02433.x","article-title":"Treatment of acquired hemophilia A","volume":"5","author":"2 Collins","year":"2007","unstructured":"2 Collins PW. Treatment of acquired hemophilia A. J Thromb Haemost. 2007; 5: 893-900.","journal-title":"J Thromb Haemost"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 Al Hennawi AH, Al Masri MK, Bakir M, et al. Acquired hemophilia a post-COVID-19 vaccination: a case report and review. Cureus 2022; 14: e21909.","DOI":"10.7759\/cureus.21909"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/jth.15291","article-title":"A case report of acquired hemophilia following COVID-19 vaccine","volume":"19","author":"Radwi M","year":"2021","unstructured":"4 Radwi M, Farsi S. A case report of acquired hemophilia following COVID-19 vaccine. J Thromb Haemost. 2021; 19: 1515-1518.","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0042-1754389","article-title":"Investigating a signal of acquired hemophilia associated with COVID-19 vaccination: a systematic case review","volume":"49","author":"5 Franchini","year":"2023","unstructured":"5 Franchini M, Cappello E, Valdiserra G, et al. Investigating a signal of acquired hemophilia associated with COVID-19 vaccination: a systematic case review. Semin Thromb Hemost. 2023; 49: 15-26.","journal-title":"Semin Thromb Hemost"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6 Sipos K. Dental management of patients with haemophilia. [Haemophili\u00e1s betegek fogorvosi ell\u00e1t\u00e1sa.] Orv Hetil. 2022; 163: 943-951. [Hungarian]","DOI":"10.1556\/650.2022.32491"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"7 Knoebl","year":"2012","unstructured":"7 Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012; 10: 622-631.","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2141.1979.tb05895.x","article-title":"Synthesis of procoagulant factor VIII, factor VIII related antigen and other coagulation factors by the isolated perfused rat liver","volume":"41","author":"8 Shaw","year":"1979","unstructured":"8 Shaw E, Giddings JC, Peake IR, et al. Synthesis of procoagulant factor VIII, factor VIII related antigen and other coagulation factors by the isolated perfused rat liver. Br J Haematol. 1979; 41: 585-596.","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","article-title":"Thrombin generation and fibrin clot structure","volume":"21","author":"9 Wolberg","year":"2007","unstructured":"9 Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev. 2007; 21: 131-142.","journal-title":"Blood Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1538-7836.2012.04793.x","article-title":"Mechanisms and monitoring of bypassing agent therapy","volume":"10","author":"Hoffman M","year":"2012","unstructured":"10 Hoffman M, Dargaud Y. Mechanisms and monitoring of bypassing agent therapy. J Thromb Haemost. 2012; 10: 1478-1485.","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/2040620717737701","article-title":"Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date","volume":"8","author":"Giansily-Blaizot M","year":"2017","unstructured":"11 Giansily-Blaizot M, Schved JF. Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date. Ther Adv Hematol. 2017; 8: 345-352.","journal-title":"Ther Adv Hematol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1445-5994.2012.02942.x","article-title":"How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors","volume":"42","author":"12 Brown","year":"2012","unstructured":"12 Brown SA, Barnes C, Curtin J, et al. How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Intern Med J. 2012; 42: 1243-1250.","journal-title":"Intern Med J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"13 Tiede","year":"2020","unstructured":"13 Tiede A, Collins P, Knoebl P, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica 2020; 105: 1791-1801.","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1182\/blood-2012-02-408930","article-title":"Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry","volume":"120","author":"14 Baudo","year":"2012","unstructured":"14 Baudo F, Collins P, Huth-K\u00fchne A, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012; 120: 39-46.","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/bjh.15175","article-title":"Activated prothrombin complex concentrate (FEIBA\u00ae)","volume":"184","author":"15 Zanon","year":"2019","unstructured":"15 Zanon E, Pasca S, Santoro K, et al. Activated prothrombin complex concentrate (FEIBA\u00ae). Br J Haematol. 2019; 184: 853-855.","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MBC.0000000000000471","article-title":"Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study","volume":"27","author":"AD","year":"2016","unstructured":"16 Ma AD, Kessler CM, Al-Mondhiry HA, et al. Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study. Blood Coagul Fibrinolysis 2016; 27: 753-760.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1182\/blood-2014-07-587089","article-title":"Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01\/2010 study","volume":"125","author":"17 Tiede","year":"2015","unstructured":"17 Tiede A, Klamroth R, Scharf RE, et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01\/2010 study. Blood 2015; 125: 1091-1097.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"120","author":"18 Collins","year":"2012","unstructured":"18 Collins P, Baudo F, Knoebl P, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood 2012; 120: 47-55.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1055\/s-0034-1390004","article-title":"Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges","volume":"40","author":"19 Tiede","year":"2014","unstructured":"19 Tiede A, Werwitzke S, Schar, RE. Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014; 40: 803-811.","journal-title":"Semin Thromb Hemost"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"20 Collins","year":"2007","unstructured":"20 Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007; 109: 1870-1877.","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/hae.13844","article-title":"Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: a global expert consensus statement","volume":"25","author":"21 Tiede","year":"2019","unstructured":"21 Tiede A, Giangrande P, Teitel J, et al. Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: a global expert consensus statement. Haemophilia 2019; 25: 969-978.","journal-title":"Haemophilia"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1365-2141.2011.08854.x","article-title":"Parallel use of by-passing agents in haemophilia with inhibitors: a critical review","volume":"155","author":"22 Ingerslev","year":"2011","unstructured":"22 Ingerslev J, S\u00f8rensen B. Parallel use of by-passing agents in haemophilia with inhibitors: a critical review. Br J Haematol. 2011; 155: 256-262.","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1182\/bloodadvances.2017011536","article-title":"Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data","volume":"1","author":"23 Rota","year":"2017","unstructured":"23 Rota M, Cortesi PA, Crea R, et al. Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data. Blood Adv. 2017; 1: 2637-2642.","journal-title":"Blood Adv"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 Zatroch I, Smudla A, Babik B, et al. Procoagulation, hypercoagulation and fibrinolytic \"shut down\" detected with ClotPro viscoelastic tests in COVID-19 patients. [Procoagulatio, hypercoagulatio \u00e9s fibrinolysis \"shut down\" kimutat\u00e1sa ClotPro\u00ae viszkoelasztikus tesztek seg\u00edts\u00e9g\u00e9vel COVID-19-betegekben.] Orv Hetil. 2020; 161: 899-907. [Hungarian]","DOI":"10.1556\/650.2020.31870"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MBC.0000000000001185","article-title":"New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9\u200a min earlier","volume":"34","author":"25 Zatroch","year":"2023","unstructured":"25 Zatroch I, Dinya E, Fazakas J. New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9\u200a min earlier. Blood Coagul Fibrinolysis 2023; 34: 99-104.","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/164\/40\/article-p1600.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/164\/40\/article-p1600.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/164\/40\/article-p1600.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T08:06:18Z","timestamp":1697789178000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/164\/40\/article-p1600.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,8]]},"references-count":25,"journal-issue":{"issue":"40"},"URL":"https:\/\/doi.org\/10.1556\/650.2023.32874","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,8]]}}}